Speech Predicts Alzheimer's; Afib and Dementia in Women; Who Gets Lecanemab? News and commentary from the world of neurology and neuroscience Jun 27, 2023
Treatment May Delay Earliest MS Events TERIS is the second trial to investigate radiologically isolated syndrome Apr 26, 2023
Novel MS Drug Good as Gold in Phase II Study Yes, we mean element no. 79 on the periodic table Apr 25, 2023
Detecting Alzheimer's in Speech; Manipulating CSF in Humans; Gut Microbiome and MS News and commentary from the world of neurology and neuroscience Apr 04, 2023
Cognitive Impairment in Multiple Sclerosis Tied to Diet Mediterranean diet was strongest predictor of better cognitive scores Mar 03, 2023
Man Presents With Episodic, One-Sided Facial Paralysis Uncommon presentation of MS detailed in case report Feb 21, 2023
Epstein-Barr/MS Link; How CBD Curtails Seizures; NIH Finds Rare Neurologic Disease News and commentary from the world of neurology and neuroscience Feb 14, 2023
Viruses Tied to Subsequent Dementia, Other Neurodegenerative Diseases Viral encephalitis and Alzheimer's disease showed strongest links Jan 30, 2023
Isolation and Dementia Risk; High-Intensity Exercise and the Brain; Migraine and MS News and commentary from the world of neurology and neuroscience Jan 17, 2023
Anti-CD20 Agent Gains Approval for Multiple Sclerosis FDA greenlights ublituximab for relapsing MS Dec 29, 2022
Pragmatic Trials May Help Increase Minority Participation in MS Research DELIVER-MS shows racial and ethnic diversity in clinical trials can be improved Nov 02, 2022
Higher Relapse Rate With Rituximab vs Ocrelizumab in MS Registry Data Rituximab did not show non-inferiority in comparative effectiveness study Nov 01, 2022
Can First MS Symptoms Be Delayed? ARISE trial investigates radiologically isolated syndrome Oct 31, 2022
New Evidence Sheds Light on Stem Cell Transplantation for Progressive MS Disability, relapses no better than disease-modifying drug Oct 30, 2022
No Excess Pregnancy, Infant Risks With Ocrelizumab for MS Major congenital anomalies, other adverse outcomes were rare Oct 28, 2022
Off-Label Drug Lowers Relapses in Multiple Sclerosis Study paves way for rituximab to be considered for MS in some countries Jul 21, 2022
Alzheimer's-Gut Links; Long COVID and ME/CFS; ALS Patient Gets Novel Brain Interface News and commentary from the world of neurology and neuroscience Jul 19, 2022
Sacral Neuromodulation Promising in Neurogenic Lower Urinary Dysfunction Refractory disease corrected, at least for the short term, in selected neurologic patients Jul 15, 2022
Therapeutic Use of Cannabis: Risks, Benefits, Legality Increased availability and use challenge clinician knowledge to keep pace Jun 29, 2022
Patient-Reported Outcomes Similar With Extended Natalizumab Dosing Interval NOVA trial looks at 6-week dosing to reduce PML risk Jun 09, 2022
High Density of MS Patients in Wisconsin -- But Why? Health records show prevalence may be three times the norm in some areas Jun 07, 2022
Plasma NfL Linked With Cognitive Processing Speed in Relapsing MS Post hoc analysis of trial data shows inverse relationship Jun 05, 2022
Quit MS Drugs or Keep Going? DISCOMS trial looks at whether MS patients should stop treatment as they age Jun 05, 2022
Women With MS Use Social Media to Discuss Family Planning Posts offer insight into risks, experiences during pregnancy Jun 04, 2022
Silent Progression in Relapsing MS Tied to Brain Volume Loss Findings highlight the need to better stratify MS patients in clinical practice May 16, 2022
White MS Prevalence Predominance Debunked Burden of multiple sclerosis in Black Americans under-recognized for decades, researchers say Apr 29, 2022
Keto Diet Bettered Fatigue, Depression in MS Quality of life, disability showed improvements in phase II study Apr 28, 2022
More Severe Multiple Sclerosis Seen Further North MS patients in higher latitudes experience faster decline Apr 18, 2022
Sleep and Light Exposure; Patients Protest CMS Plan; Lamotrigine's Cardiac Risks? News and commentary from the world of neurology and neuroscience Mar 15, 2022
MS Patients on Cladribine Show Fewer Relapses Real-world data analysis compares oral disease-modifying therapies Mar 01, 2022
Stem Cell Transplantation Shows Benefits in Aggressive MS No new relapses recorded after autologous transplant Feb 28, 2022
Deep Learning Identifies PPMS Patients Who May Respond to Treatment Predictive enrichment could increase the power of future trials Feb 27, 2022
Paramagnetic Rim Lesions Highly Specific in MS Diagnosis Sensitivity, accuracy also high in prospective study Feb 26, 2022
COVID Vax Response Still Impaired in Some MS Patients After Third Shot Subset of multiple sclerosis patients seroconverted after third dose, however Feb 25, 2022
Cialis and Brain Blood Flow; Sleep and Media Use; Can Tarantulas Solve Chronic Pain? News and commentary from the world of neurology and neuroscience Feb 15, 2022
MS Risk Skyrockets After Epstein-Barr Virus, but Not Other Infections Findings show "compelling evidence of causality" Jan 13, 2022
Worse COVID-19 Outcomes for Disabled MS Patients But monoclonal antibodies offer hope for high-risk people, registry data show Nov 02, 2021
MS Treatment: Early Aggressive or Escalation Therapy? Clinical trial, observational data may not be enough to decide best strategy Nov 01, 2021
New MS Drug Does Not Appear to Increase COVID Severity Most COVID cases were mild or moderate in patients treated with ofatumumab Oct 29, 2021
Cannabis Use Common Among People With MS Most don't ask for medical guidance, survey shows Oct 28, 2021
